NRC logo

NRC
National Research Corp

154
Mkt Cap
$374.86M
Volume
72,612.00
52W High
$22.79
52W Low
$9.76
PE Ratio
32.89
NRC Fundamentals
Price
$16.48
Prev Close
$17.05
Open
$16.97
50D MA
$15.76
Beta
0.72
Avg. Volume
115,767.05
EPS (Annual)
$0.5042
P/B
26.67
Rev/Employee
$384,845.94
$496.02
Loading...
Loading...
News
all
press releases
National Research (NASDAQ:NRC) Shares Pass Above 200-Day Moving Average - Here's What Happened
National Research (NASDAQ:NRC) Stock Passes Above Two Hundred Day Moving Average - Here's Why...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Ann & Robert H. Lurie Childrens Hospital of Chicago Expands Partnership with NRC Health to Strengthen Consumer Insight and Online Reputation Strategy
NRC Health today announced that Ann & Robert H. Lurie Childrens Hospital of Chicago has further expanded its partnership to include NRC Healths Reputation, alongside its continued use of NRC Healths...
Business Wire·5d ago
News Placeholder
National Research (NASDAQ:NRC) Share Price Passes Above Two Hundred Day Moving Average - What's Next?
National Research (NASDAQ:NRC) Shares Pass Above 200-Day Moving Average - Should You Sell...
MarketBeat·10d ago
News Placeholder
National Research Corporation (NASDAQ:NRC) Plans $0.16 Quarterly Dividend
National Research Corporation (NASDAQ:NRC) announced a quarterly dividend on Wednesday, January 21st. Stockholders of record on Friday, March 27th will be paid a dividend of 0.16 per share on Friday...
MarketBeat·18d ago
News Placeholder
Piedmont Names NRC Health as a Strategic Experience Partner to Support Mission-Driven Growth
Piedmont, a Georgia-based healthcare system with nationally-ranked clinical programs, has named NRC Health, the leader in healthcare experience management, as its new strategic experience partner to...
Business Wire·24d ago
News Placeholder
National Research (NASDAQ:NRC) Stock Passes Above Two Hundred Day Moving Average - Here's Why
National Research (NASDAQ:NRC) Stock Passes Above 200-Day Moving Average - What's Next...
MarketBeat·25d ago
News Placeholder
The Zacks Analyst Blog Oracle, T-Mobile, Gilead, and C&F Financial
Oracle's AI-driven cloud surge, T-Mobile's 5G edge, and Gilead's dominant HIV franchise headline today's top analyst reports and highlight key growth drivers.
Zacks·1mo ago
News Placeholder
Top Stock Reports for Oracle, T-Mobile & Gilead
Oracle's cloud infrastructure revenue jumped 84% in fiscal Q3 as AI and multicloud demand surged, though heavy data-center investments pushed trailing free cash flow to -$13.2B.
Zacks·1mo ago
News Placeholder
National Research (NASDAQ:NRC) Shares Pass Above 200 Day Moving Average - Time to Sell?
National Research (NASDAQ:NRC) Shares Cross Above 200-Day Moving Average - Here's Why...
MarketBeat·1mo ago
News Placeholder
NRC Health Announces Board Authorization of $60 Million Share Repurchase Program
National Research Corporation, dba NRC Health, (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced that its Board of Directors authorized a stock repurchase...
Business Wire·1mo ago
<
1
2
...
>

Latest NRC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.